Discovery, Chemistry, and Preclinical Development of Pritelivir, a Novel Treatment Option for Acyclovir-Resistant Herpes Simplex Virus Infections-Reference-Cited by-同舟云学术

Discovery, Chemistry, and Preclinical Development of Pritelivir, a Novel Treatment Option for Acyclovir-Resistant Herpes Simplex Virus Infections

Published:2022-10-06 Issue:20 Volume:65 Page:13614-13628
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Birkmann Alexander¹^ORCID,Bonsmann Susanne¹,Kropeit Dirk¹,Pfaff Tamara¹,Rangaraju Manickam¹,Sumner Melanie¹,Timmler Burkhard¹,Zimmermann Holger¹,Buschmann Helmut¹,Ruebsamen-Schaeff Helga¹

Affiliation:

1. AiCuris Anti-Infective Cures AG, 42117 Wuppertal, Germany

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.2c00668

Reference69 articles.

1. Evolutionary Origins of Human Herpes Simplex Viruses 1 and 2

2. Network analysis of the hominin origin of Herpes Simplex virus 2 from fossil data

3. Clinical management of herpes simplex virus infections: past, present, and future

4. Current Drugs to Treat Infections with Herpes Simplex Viruses-1 and -2

5. HSV antivirals – current and future treatment options

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The immunobiology of corneal HSV-1 infection and herpetic stromal keratitis;Clinical Microbiology Reviews;2024-09-12

2. Helicase-primase inhibitors for the treatment of herpes simplex virus infections – patent evaluation of WO2023/225162 from gilead sciences inc;Expert Opinion on Therapeutic Patents;2024-09-11

3. Replacement of sulfonamide by sulfoximine within a helicase-primase inhibitor with restricted flexibility;Bioorganic & Medicinal Chemistry Letters;2024-07

4. Advances and prospect in herpesviruses infections after haematopoietic cell transplantation: closer to the finish line?;Clinical Microbiology and Infection;2024-06

5. Evaluation of the Clinical Drug‐Drug Interaction Potential of Pritelivir on Transporters and CYP450 Enzymes Using a Cocktail Approach;Clinical Pharmacology in Drug Development;2024-05-16